| Cancer stem cells in colorectal cancer: a review |
34 |
| Testing algorithm for identification of patients with TRK fusion cancer |
33 |
| PD-L1 |
32 |
| Subcellular localisation of the stem cell markers OCT SOX NANOG, KLF4 and c-MYC in cancer: a review |
30 |
| Immune checkpoint inhibitor-induced gastrointestinal and hepatic injury: pathologists' perspective |
25 |
| CDK12: an emerging therapeutic target for cancer |
17 |
| Review of diagnostic error in anatomical pathology and the role and value of second opinions in error prevention |
14 |
| Fluid-based assays and precision medicine of cardiovascular diseases: the 'hope' for Pandora's box? |
13 |
| RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implications |
12 |
| Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors |
11 |
| Molecular pathology of neurodegenerative diseases: principles and practice |
11 |
| Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples |
11 |
| International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome |
10 |
| Three-tiered score for Ki-67 and p16(ink4a) improves accuracy and reproducibility of grading CIN lesions |
10 |
| p16 |
10 |
| A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies |
10 |
| miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma |
10 |
| Expression and prognostic significance of ECT2 in invasive breast cancer |
10 |
| Circular PVT1: an oncogenic non-coding RNA with emerging clinical importance |
9 |
| Laboratory assessment of folate (vitamin B-9) status |
9 |
| HbA1c: a review of non-glycaemic variables |
9 |
| Comparison of haemoglobin assessments by HemoCue and two automated haematology analysers in young Laotian children |
8 |
| Correlation of immunohistochemical mismatch repair protein status between colorectal carcinoma endoscopic biopsy and resection specimens |
8 |
| Setting up a service for a faecal immunochemical test for haemoglobin (FIT): a review of considerations, challenges and constraints |
8 |
| Prognostic impact of p16 and PD-L1 expression in patients with oropharyngeal squamous cell carcinoma receiving a definitive treatment |
8 |
| Digital pathology access and usage in the UK: results from a national survey on behalf of the National Cancer Research Institute's CM-Path initiative |
8 |
| Opinion: redefining the role of the physician in laboratory medicine in the context of emerging technologies, personalised medicine and patient autonomy ('4P medicine') |
7 |
| Investigation and management of subfertility |
7 |
| Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma |
7 |
| Gene of the month: SDH |
7 |
| Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease |
7 |
| Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours |
7 |
| High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma |
7 |
| A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day |
6 |
| FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer |
6 |
| TERT gene: its function and dysregulation in cancer |
6 |
| Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology |
6 |
| PD-L1 expression on routine samples of non-small cell lung cancer: results and critical issues from a 1-year experience of a centralised laboratory |
6 |
| Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma |
6 |
| Clinical utility of reflex testing using focused next-generation sequencing for management of patients with advanced lung adenocarcinoma |
6 |
| Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer |
6 |
| Disorders of phosphate metabolism |
6 |
| Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast |
6 |
| The relevance and implications of signet-ring cell adenocarcinoma of the oesophagus |
6 |
| Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories |
6 |
| Genetics and genomics of breast fibroadenomas |
6 |
| HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Committee |
6 |
| Normative data for flow cytometry immunophenotyping of benign lymph nodes sampled by surgical biopsy |
6 |
| Recurrent MED12 exon 2 mutations in benign breast fibroepithelial lesions in adolescents and young adults |
6 |
| Clinical significance of FAP-alpha on microvessel and lymphatic vessel density in lung squamous cell carcinoma |
5 |
